NCT02511002View on ClinicalTrials.gov

Long-term Observation of Hemagglutinin and Neuraminidase Inhibition Antibody Titers After Influenza Challenge

Enrolling by invitationOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

July 17, 2015

Primary Completion Date

May 12, 2027

Study Completion Date

May 12, 2027

Conditions
Post Influenza
Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH